Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jose Manuel Perez Garcia"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jose Manuel Perez Garcia, Erika Hitre, Boguslawa Karaszewska, Jacinta Abraham, Eleonora Restuccia, Carlo Tondini, Alejandro Juarez, Mark C. Benyunes, Miguel Martín, Zbigniew Nowecki, Adam Knott, Sherko Kümmel, Bartosz Itrych, Flavia Morales-Vásquez, Servando Cardona-Huerta, Marco Sequi, Estefania Monturus
Publikováno v:
Cancer Research. 80:P1-18
Background Previous trials showed that fixed-dose subcutaneous trastuzumab and hyaluronidase-oysk (Herceptin Hylecta™; H SC) was non-inferior to weight-based intravenous trastuzumab (Herceptin®; H IV) in terms of pathologic complete response and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6028481b25b74fb00eec40d9ef710f12
https://doi.org/10.1158/1538-7445.sabcs19-p1-18-05
https://doi.org/10.1158/1538-7445.sabcs19-p1-18-05
Autor:
Mario Campone, David M. Hyman, Matthew C.H. Ng, John Sarantopoulos, Ulka N. Vaishampayan, A. Craig Lockhart, Giuseppe Curigliano, Xueying Chen, Jennifer Bendiske, Rashmi Chugh, Thomas Zander, Jose Manuel Perez Garcia, Philippe A. Cassier, Amit Mahipal, Nancy Lewis, Philippe L. Bedard, María José De Miguel-Luken, Somesh Choudhury, Diana Graus-Porta, Cristiana Sessa, Luis Paz-Ares, Jan H.M. Schellens, Ben Tran, Jean-Pascal Machiels
Publikováno v:
JCO precision oncology, Vol. 3, no.1, p. 1-13 (2019)
PURPOSE Concurrent PIK3CA mutations and fibroblast growth factor receptor (FGFR) alterations occur in multiple cancer types, including estrogen receptor–positive breast cancer, bladder cancer, and endometrial cancer. In this first-in-human combinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc514bf7ed468301f9a98ab3a7021bb
https://pubmed.ncbi.nlm.nih.gov/35100734
https://pubmed.ncbi.nlm.nih.gov/35100734
Autor:
Rajwinder Lehal, Omar Saavedra Santa Gadea, Maria Bobadilla, Fabricio Racca, Jordi Rodon, Elena Garralda, Michael Pascal Bauer, Jose Manuel Perez Garcia, Javier Cortes, Anastasios Stathis, Michele Vigolo, Renata Ferrarotto, Dagmar Hess, Doris Quon, Elena Lopez Miranda, Florian D. Vogl, Ana Vivancos, Oliver Schönborn-Kellenberger, Paolo Nuciforo, Laura Beni
Publikováno v:
Journal of Clinical Oncology. 39:3020-3020
3020 Background: CB-103 selectively inhibits the CSL-NICD interaction leading to down-regulation of CSL-NICD mediated oncogenic pathway activation downstream of NOTCH receptor/ligand signaling, and has shown potent anti-cancer activity as single agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a6802749338369fd0f4c7305bbbcdce
https://doi.org/10.1200/jco.2021.39.15_suppl.3020
https://doi.org/10.1200/jco.2021.39.15_suppl.3020
Autor:
Karlos Alexandre de Souza Vilarinho, Pedro Paulo Martins de Oliveira, Elaine Soraya Barbosa de Oliveira Severino, Tomas G. Neilan, José Roberto Matos Souza, Lindemberg da Mota Silveira Filho, Carlos Fernando Ramos Lavagnoli, Otávio Rizzi Coelho, Ravi V. Shah, Jose Carlos Barros, Venkatesh L. Murthy, Jose Manuel Perez Garcia, Michael Jerosch-Herold, Marc J. Semigran, Otavio R. Coelho-Filho, Orlando Petrucci
Publikováno v:
The International Journal of Cardiovascular Imaging. 34:15-24
After orthotopic heart transplantation (OHT), the allograft undergoes characteristic alterations in myocardial structure, including hypertrophy, increased ventricular stiffness, ischemia, and inflammation, all of which may decrease overall graft surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3516bfce0adadcec10df1a03b0bffdc
https://doi.org/10.1007/s10554-016-0937-6
https://doi.org/10.1007/s10554-016-0937-6
Autor:
Kathleen M. McEachern, Marlene L. Durand, Jose Manuel Perez Garcia, Gregory D. Lewis, Joshua N. Baker, Thomas E. MacGillivray, Stephanie Ennis, Camille N. Kotton, Janice M. Camuso
Publikováno v:
Artificial Organs. 41:169-175
This retrospective cohort study evaluated the effect of topical polymyxin-trimethoprim (poly) prophylaxis on the incidence of driveline infections (DLIs) in patients with continuous-flow left ventricular assist devices. All 84 cases implanted 2005-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::487ee67cfdb66d8f97dd3a5e5e532438
https://doi.org/10.1111/aor.12726
https://doi.org/10.1111/aor.12726
Autor:
P García, J. Florián, P. Zamora, Sonia Servitja, A. Velasco, M. A. Seguí, E Artime, L. De Paz, J de la Haba, Eduardo Martínez, Jose Manuel Perez Garcia, Ana Santaballa, J. Rodríguez-Villanueva, I Chacón, Y Plata, I Garau
Publikováno v:
Cancer Research. 76:P3-07
BACKGROUND: Currently available therapeutic armamentarium for locally advanced and/or metastatic breast cancer (LA/MBC) allows an increasing tailored approach for each of the major tumor immunophenotypes. Nevertheless, there is scarce information abo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b521268f2bfcc5870683e4396893cf59
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-39
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-39
Autor:
Laura G. Estévez, Rafael Jacinto Villanueva, Jose Alejandro Perez-Fidalgo, Sung Bae Kim, Aditya Bardia, Valentina Boni, Sharareh Monemi, Ya-Chi Chen, Sherene Loi, Joohyuk Sohn, Mary Gates, Komal Jhaveri, Nicholas C. Turner, Seock-Ah Im, Heather M. Moore, Meritxell Bellet, Sara Lopez-Tarruella Cobo, Elgene Lim, Jose Manuel Perez Garcia
Publikováno v:
Journal of Clinical Oncology. 38:1023-1023
1023 Background: GDC-9545 is a potent, orally available, selective estrogen receptor degrader developed for the treatment of ER-positive (ER+) breast cancer alone or combined with CDK4/6 inhibitors. A first-in-human study evaluated 10-250 mg GDC-9545
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9b078fb3958701d4f93b8fdedf09de4
https://doi.org/10.1200/jco.2020.38.15_suppl.1023
https://doi.org/10.1200/jco.2020.38.15_suppl.1023
Autor:
Thoralf M. Sundt, Sunu S. Thomas, Gregory D. Lewis, Marc J. Semigran, Nosheen Reza, Christopher Newton-Cheh, Stephen A. McCullough, Venkatesh L. Murthy, Jose Manuel Perez Garcia, Joshua N. Baker, Brett J Carroll, Tae H. Song, Ravi V. Shah, Tom MacGillivray, Janice M. Camuso
Publikováno v:
The American Journal of Cardiology. 116:1624-1630
Extracorporeal membrane oxygenation (ECMO) is an increasingly used supportive measure for patients with refractory cardiogenic shock (CS). Despite its increasing use, there remain minimal data regarding which patients with refractory CS are most like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fd6e404a4a79a7bb4f95acf184f7b0
https://doi.org/10.1016/j.amjcard.2015.08.030
https://doi.org/10.1016/j.amjcard.2015.08.030
Autor:
Keshava Rajagopal, Marc Gibber, Joseph Rabin, P. Brody Wehman, Jose Manuel Perez Garcia, Daniel Herr, Aldo Iacono, Zachary N. Kon, Bartley P. Griffith, Charles F. Evans
Publikováno v:
The Annals of Thoracic Surgery. 99:704-707
We present a case of a woman with acute respiratory distress syndrome and irrecoverable lung function that was successfully bridged to lung transplantation after 155 consecutive days of venovenous extracorporeal membrane oxygenation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9b5cbc82416a488ecbe281e05a64ba
https://doi.org/10.1016/j.athoracsur.2014.04.097
https://doi.org/10.1016/j.athoracsur.2014.04.097